Patents by Inventor Eivind Hovig

Eivind Hovig has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220409582
    Abstract: The present invention relates to compositions and methods for treatment of cholangiocarcinoma and in particular to combination therapies comprising panobinostat compositions in combination with other cytotoxic agents, e.g. agents that potentiate the effects of panobinostat, for use in the treatment of cholangiocarcinoma. Pharmaceutical compositions comprising panobinostat and other cytotoxic agents are also provided.
    Type: Application
    Filed: September 11, 2020
    Publication date: December 29, 2022
    Inventors: Theresa AHRENS, Alexandra GADE, Eivind HOVIG, Jo KLAVENESS, Johannes LANDSKRON, Kjetil TASKEN, Tove Cecilie VIEBE
  • Publication number: 20110171184
    Abstract: The present application relates to a method for introducing a PNA molecule into the cytosol, preferably the nucleus of a cell, comprising contacting said cell with a PNA molecule and a photosensitising agent, and irradiating the cell with light of a wavelength effective to activate the photosensitising agent, wherein said PNA molecule is conjugated to a positively charged peptide. Compositions comprising such conjugated PNA molecules, cells made using the method and uses of the method are also described.
    Type: Application
    Filed: July 7, 2005
    Publication date: July 14, 2011
    Applicant: PCI Biotech AS
    Inventors: Eivind Hovig, Oystein Fodstad, Sigurd Boe
  • Patent number: 7162465
    Abstract: A method for indexing, extracting, analyzing, and utilizing co-occurrences of logical concepts in text documents is disclosed. References to logical concepts are detected by a text processing procedure by detection of descriptors, e.g., names, also including abbreviations, from a hierarchical dictionary with names and synonyms for said logical concepts, or database identifiers. Co-occurring concepts are indexed and stored in a database as a list or a table. Analysis of co-occurrences detects expressed and implied relationships between co-occurring concepts based on statistical and lexical text analysis. The method includes a procedure to create domain-specific hierarchical dictionaries for logical concepts in a given domain.
    Type: Grant
    Filed: December 20, 2002
    Date of Patent: January 9, 2007
    Inventors: Tor-Kristian Jenssen, Eivind Hovig
  • Publication number: 20030225773
    Abstract: A method for indexing, extracting, analyzing, and utilizing co-occurrences of logical concepts in text documents is disclosed. References to logical concepts are detected by a text processing procedure by detection of descriptors, e.g., names, also including abbreviations, from a hierarchical dictionary with names and synonyms for said logical concepts, or database identifiers. Co-occurring concepts are indexed and stored in a database as a list or a table. Analysis of co-occurrences detects expressed and implied relationships between co-occurring concepts based on statistical and lexical text analysis. The method includes a procedure to create domain-specific hierarchical dictionaries for logical concepts in a given domain.
    Type: Application
    Filed: December 20, 2002
    Publication date: December 4, 2003
    Inventors: Tor-Kristian Jenssen, Eivind Hovig
  • Patent number: 6607886
    Abstract: The present invention relates to a method and apparatus for simultaneous quantification of the amounts of one or more radioactive nuclides within arbitrary regions on a surface where these nuclides have been deposited, adsorbed or fixed. These radioactive nuclides serve as markers on compounds that typically have been incorporated into tissue sections or into larger biological molecules that by various mechanisms have been bound to chemical substances on this surface. The method is especially well suited for DNA microarray deductions through the use of nucleotides labelled with different beta-emitting radionuclides.
    Type: Grant
    Filed: February 1, 2001
    Date of Patent: August 19, 2003
    Assignee: Biomolex AS
    Inventors: Eivind Hovig, Arne Skretting, Einar Nygard, Yngve Kvinnsland, Knut Breistol, Koki Yoshioka
  • Publication number: 20020142301
    Abstract: The present invention relates to a method and apparatus for simultaneous quantification of the amounts of one or more radioactive nuclides within arbitrary regions on a surface where these nuclides have been deposited, adsorbed or fixed. These radioactive nuclides serve as markers on compounds that typically have been incorporated into tissue sections or into larger biological molecules that by various mechanisms have been bound to chemical substances on this surface. The method is especially well suited for DNA microarray deductions through the use of nucleotides labelled with different beta-emitting radionuclides.
    Type: Application
    Filed: February 1, 2001
    Publication date: October 3, 2002
    Inventors: Eivind Hovig, Arne Skretting, Einar Nygard, Yngve Kvinnsland, Knut Breistol, Koki Yoshioka
  • Patent number: 5877308
    Abstract: Disclosed are synthetic oligonucleotides having a nucleotide sequence complementary to CAPL nucleic acid. Also disclosed are methods of inhibiting the expression of CAPL gene and methods of inhibiting metastatic cancer using CAPL-specific oligonucleotides.
    Type: Grant
    Filed: May 3, 1996
    Date of Patent: March 2, 1999
    Assignees: Hybridon, Inc., Norwegian Radium Hospital Research Foundation
    Inventors: Oystein Fodstad, Eivind Hovig, Olav Engebraaten, Gunhild Maelandsmo, Sudhir Agrawal, Eric von Hofe
  • Patent number: 5872007
    Abstract: Disclosed are synthetic oligonucleotides having a nucleotide sequence complementary to CAPL nucleic acid. Also disclosed are methods of inhibiting the expression of CAPL gene and methods of inhibiting metastatic cancer using CAPL-specific oligonucleotides.
    Type: Grant
    Filed: July 14, 1995
    Date of Patent: February 16, 1999
    Assignee: Hybridon, Inc.
    Inventors: Oystein Fodstad, Eivind Hovig, Olav Engebraaten, Gunhild Maelandsmo, Sudhir Agrawal
  • Patent number: 5789248
    Abstract: Disclosed are synthetic oligonucleotides having a nucleotide sequence complementary to CAPL nucleic acid. Also disclosed are methods of inhibiting the expression of CAPL gene and methods of inhibiting metastatic cancer using CAPL-specific oligonucleotides.
    Type: Grant
    Filed: February 16, 1996
    Date of Patent: August 4, 1998
    Assignees: Hybridon, Inc., Norwegian Radium Hospital Research Foundation
    Inventors: Oystein Fodstad, Eivind Hovig, Olav Engebraaten, Gunhild Maelandsmo, Sudhir Agrawal